Skip to content

RECURSION PHARMACEUTICALS, INC.

RXRX · XNAS

CIK 1601830fmd_1P9BMY6J0J6GD4E7ZYCBVRS2ESManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods

0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading